Skip to main content
. 2022 Dec 27;59(1):53. doi: 10.3390/medicina59010053

Table 4.

Clinical investigations at hospital admission of the study population.

Clinical Investigations Tocilizumab
(n = 110) (1)
Control
(n = 630) (1)
p Value (2)
CT Scan Findings Ground glass opacity 53 (48.2%) 352 (55.9%) 0.001 F
Infiltrations 2 (1%) 19 (3%)
Major abnormality 14 (12.7%) 80 (12.7%)
Mixed ground glass opacity and Infiltrations 37 (33.6%) 66 (10.5%)
Patchy shadowing 4 (3.6%) 113 (17.9%)

(1) n (%); (2) F = Fisher’s exact test.